Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$2.75−0.26 (-8.80%)
Close on Nov 18, 2026Market cap $53.09MP/E –Yield –
Corbus Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Corbus Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$86.67M. For fiscal 2025 it was -$64.49M. The highest annual figure on record is -$366.72K in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$64.49M | – |
| FY2024 | Dec 31, 2024 | -$41.79M | – |
| FY2023 | Dec 31, 2023 | -$36.10M | – |
| FY2022 | Dec 31, 2022 | -$37.54M | – |
| FY2021 | Dec 31, 2021 | -$48.18M | – |
| FY2020 | Dec 31, 2020 | -$99.69M | – |
| FY2019 | Dec 31, 2019 | -$45.72M | – |
| FY2018 | Dec 31, 2018 | -$30.07M | – |
| FY2017 | Dec 31, 2017 | -$27.80M | – |
| FY2016 | Dec 31, 2016 | -$13.57M | – |
| FY2015 | Dec 31, 2015 | -$4.62M | – |
| FY2014 | Dec 31, 2014 | -$2.36M | – |
| FY2013 | Dec 31, 2013 | -$366.72K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$29.63M | – |
| Q1 FY2026 | Mar 31, 2026 | -$25.57M | – |
| Q4 FY2025 | Dec 31, 2025 | -$15.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.42M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.97M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.01M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.25M | -945.4% |
| Q2 FY2022 | Jun 30, 2022 | -$12.23M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.70M | – |
| Q3 FY2021 | Sep 30, 2021 | $856.95K | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$21.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.22M | – |
| Q3 FY2020 | Sep 30, 2020 | -$27.25M | – |
| Q2 FY2020 | Jun 30, 2020 | -$26.61M | – |
| Q1 FY2020 | Mar 31, 2020 | -$27.60M | -367.5% |
| Q4 FY2019 | Dec 31, 2019 | -$22.56M | – |
| Q3 FY2019 | Sep 30, 2019 | -$17.09M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.39M | – |
| Q1 FY2019 | Mar 31, 2019 | $10.32M | – |
| Q4 FY2018 | Dec 31, 2018 | -$14.06M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.85M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.56M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.11M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.71M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.64M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.05M | – |
See a number that looks wrong?